Potential Nitrosamine Contamination Results in Another Voluntary Pharmaceutical Recall | Nelson Mullins Riley & Scarborough LLP

On March 22, 2023, at the request of the U.S. Food and Drug Administration (“FDA”), Ascend Laboratories LLC. (“Ascend”) issued a voluntary nationwide recall of certain lots of...

Related Keywords

Nelson Mullins ,Bloomberg Sept ,Nelson Mullins Riley Scarborough ,Ascend Laboratories ,Drug Administration ,Bloomberg ,Morgan Stanley ,Nelson Mullins Riley ,Dabigatran Etexilate Capsules ,Nitrosamine Impurities ,Voluntary Recalls ,Products Liability ,Drug Admin ,Voluntary Nationwide Recall ,Human Drugs ,Market Withdrawals ,Safety Alerts ,New Contaminant Found ,